Company Analysis

DarioHealth Corp. (DRIO)

Nasdaq: DRIO · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2011
Grade3.2
◀ Past 2.5● Present 3.5▶ Future 3.5
1 est.

Who runs DarioHealth Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Raphael Erez
Chief Executive Officer. First filing Mar 2016, latest Sep 28, 2026, 24 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
28 people on the record since 2013
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Raphael ErezChief Executive OfficerMar 2016Sep 28, 2026none
Franco-Yehuda ChenChief Financial OfficerMay 2025Sep 28, 2026none
Sherman Lara AnnChief Operating OfficerSep 2026Sep 28, 2026none
Nelson Steven CharlesPresident and CCOJun 2024Sep 15, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Karah HiladirectorMar 2016Sep 28, 2026none
Matheis DennisdirectorJul 2020Sep 28, 2026none
Mcgrath Dennis MdirectorMar 2016Sep 28, 2026none
Palumbo John RdirectorApr 2026Sep 28, 2026none
Shaked YoavdirectorJul 2018Sep 28, 2026none
Stern Adam KdirectorFeb 2013Sep 28, 2026none
Leisure Lawrence B.directorMar 2025Sep 15, 2025none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton DRIO · research, not advice